Status:
TERMINATED
Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD
Lead Sponsor:
University of Arkansas
Conditions:
Bronchopulmonary Dysplasia
Eligibility:
All Genders
28-1 years
Phase:
NA
Brief Summary
Patients will be randomized to begin the study with either NAVA-synchronized or continuous HFNC. Each patient will receive two 15-minute trials at different levels of continuous HFNC and two 15-minute...
Detailed Description
Prior to the study period each subject will have the following monitoring equipment placed (if not already present): Edi catheter, transcutaneous monitor (TCM4, Radiometer, Brea, CA, USA) to measure C...
Eligibility Criteria
Inclusion
- Chronological age greater than 28 days
- Gestational age at birth less than 32 weeks and 6 days
- Diagnosis of BPD (supplemental oxygen requirement for greater than or equal to 28 days)
- Currently receiving noninvasive ventilation support (NIV NAVA, NIPPV, nCPAP, HFNC)
Exclusion
- Major congenital anomalies of the heart and lungs
- Post menstrual age greater than 50 weeks 0 days
- Oxygen requirement greater than 40%
Key Trial Info
Start Date :
December 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2021
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04274192
Start Date
December 9 2020
End Date
January 28 2021
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202